This is an old revision of the document!
Foundation for the National Institutes of Health
The Foundation for the National Institutes of Health (FNIH) is an American not-for-profit charity that raises private sector funds to support the mission of the National Institutes of Health (NIH).
History
The FNIH was founded by the U.S. Congress in 1990.1)
COVID-19
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
On April 17, 2020, the NIH announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership to develop a coordinated research strategy for prioritizing and speeding up development of COVID-19 vaccines and pharmaceutical products.2) ACTIV is a collaboration with Biomedical Advanced Research and Development Authority (BARDA), Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), the US Department of Defense (DOD), the Department of Veterans Affairs (VA), Countermeasures Acceleration Group (formerly Operation Warp Speed), and the European Medicines Agency (EMA).
FNIH Pandemic Response Fund
The FNIH Pandemic Response Fund was created to assist Dr. Francis Collins and Dr. Anthony Fauci in their “efforts to rapidly end the threat from COVID-19.”3)
Affiliations
Donors
As listed on the 2020 FNIH donor report.4)
| Name | Amount | Notes |
|---|---|---|
| AbbVie | $2,500,000 - $4,999,999 | 10 consecutive years of donations |
| Aligning Science Across Parkinson’s (ASAP) | $1,000,000 - $2,499,999 | - |
| Alzheimer's Association | $2,500,000 - $4,999,999 | 16 consecutive years of donations |
| Amgen | $1,000,000 - $2,499,999 | 18 consecutive years of donations |
| Bill & Melinda Gates Foundation | $10,000,000+ | 19 consecutive years of donations |
| Boehringer Ingelheim | $2,500,000 - $4,999,999 | 3 consecutive years of donations |
| Bristol-Meyers Squibb | $2,500,000 - $4,999,999 | 4 consecutive years of donations |
| Eli Lilly | $5,000,000 - $9,999,999 | 21 consecutive years of donations |
| Eisai | $2,500,000 - $4,999,999 | - |
| GlaxoSmithKline | $5,000,000 - $9,999,999 | 22 consecutive years of donations |
| Johnson & Johnson | $5,000,000 - $9,999,999 | 20 consecutive years of donations |
| Merck | $2,500,000 - $4,999,999 | 23 consecutive years of donations |
| National Institutes of Health | $2,500,000 - $4,999,999 | 24 consecutive years of donations |
| Otsuka | $2,500,000 - $4,999,999 | - |
| Pfizer | $5,000,000 - $9,999,999 | 23 consecutive years of donations |
| Takeda | $2,500,000 - $4,999,999 | 13 consecutive years of donations |
| Wellcome Trust | $5,000,000 - $9,999,999 | 2 consecutive years of donations |
1)
Menetski, J. P., Hoffmann, S. C., Cush, S. S., Kamphaus, T. N., Austin, C. P., Herrling, P. L., & Wagner, J. A. (2019). The Foundation for the National Institutes of Health Biomarkers Consortium: Past accomplishments and new strategic direction. Clinical Pharmacology & Therapeutics, 105(4), 829–843. https://doi.org/10.1002/cpt.1362
2)
ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from https://archive.ph/8eMTV
3)
Pandemic Response Fund Donation Form. The Foundation for the National Institutes of Health. Retrieved April 1, 2022, from https://archive.ph/u8wkD
4)
2020 Donors. Foundation for the National Institutes of Health. Retrieved April 2, 2022, from https://web.archive.org/web/20220316135206/https://2020-annual-report.fnih.org/donors/